Toxic megacolon primary prevention: Difference between revisions
(Created page with "__NOTOC__ {{Toxic megacolon}} Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing. {{CMG}} ==Overvie...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Toxic megacolon}} | {{Toxic megacolon}} | ||
{{CMG}}; {{AE}} | |||
==Overview== | ==Overview== | ||
There are no established measures for the primary prevention of [disease name]. | |||
OR | |||
There are no available vaccines against [disease name]. | |||
OR | |||
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3]. | |||
OR | |||
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Primary Prevention== | |||
*There are no established measures for the primary prevention of [disease name]. | |||
*There are no available vaccines against [disease name]. | |||
OR | |||
*Effective measures for the primary prevention of [disease name] include: | |||
**[Measure1] | |||
**[Measure2] | |||
**[Measure3] | |||
OR | |||
*[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include: | |||
**[Strategy 1] | |||
**[Strategy 2] | |||
**[Strategy 3] | |||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
{{ | {{WH}} | ||
{{ | {{WS}} | ||
[[Category: (name of the system)]] |
Revision as of 20:09, 25 October 2017
Toxic Megacolon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic megacolon primary prevention On the Web |
American Roentgen Ray Society Images of Toxic megacolon primary prevention |
Risk calculators and risk factors for Toxic megacolon primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
Primary Prevention
- There are no established measures for the primary prevention of [disease name].
- There are no available vaccines against [disease name].
OR
- Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
- [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]